Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Br J Cancer. 2024 May;130(8):1295-1303. doi: 10.1038/s41416-024-02593-y. Epub 2024 Feb 22.
Previous studies have observed inconsistent associations between birth weight and aggressive prostate cancer risk. This study aimed to prospectively analyse this association in the Health Professionals Follow-up Study (HPFS).
Birth weight was self-reported in 1994, and prostate cancer diagnoses were assessed biennially through January 2017 and confirmed by medical record review. Multivariable Cox proportional hazards regression was used to evaluate the association between birth weight and prostate cancer risk and mortality.
Among 19,889 eligible men, 2520 were diagnosed with prostate cancer, including 643 with higher-grade/advanced stage, 296 with lethal, and 248 with fatal disease. Overall, no association was observed for increasing birth weight with risk of overall prostate cancer, lower-grade, and organ-confined disease. However, a borderline statistically significant positive trend was observed for increasing birth weight with risk of higher-grade and/or advanced-stage prostate cancer (adjusted hazard ratio [HR] per pound: 1.05; 95% confidence interval [CI]: 0.99-1.11; P-trend = 0.08), but no associations were observed with risk of lethal or fatal disease (HR: 0.99, 95% CI: 0.91-1.08; P-trend = 0.83; and HR: 0.99, 95% CI: 0.90-1.08; P-trend = 0.82, respectively).
No consistent associations were observed between birth weight and prostate cancer risk or mortality in this 22-year prospective cohort study.
先前的研究观察到出生体重与侵袭性前列腺癌风险之间的关联并不一致。本研究旨在前瞻性分析健康专业人员随访研究(HPFS)中的这种关联。
1994 年自行报告出生体重,每两年通过 2017 年 1 月评估前列腺癌诊断情况,并通过病历审查进行确认。多变量 Cox 比例风险回归用于评估出生体重与前列腺癌风险和死亡率之间的关系。
在 19889 名符合条件的男性中,有 2520 人被诊断患有前列腺癌,其中 643 人患有高级/晚期前列腺癌,296 人患有致命性前列腺癌,248 人患有致死性前列腺癌。总体而言,出生体重增加与总体前列腺癌、低级别和器官局限性疾病的风险之间没有关联。然而,出生体重增加与高级别和/或晚期前列腺癌的风险呈临界统计学意义上的正相关趋势(每磅体重调整后的危险比[HR]:1.05;95%置信区间[CI]:0.99-1.11;P 趋势=0.08),但与致命性或致死性前列腺癌的风险无关联(HR:0.99,95%CI:0.91-1.08;P 趋势=0.83;HR:0.99,95%CI:0.90-1.08;P 趋势=0.82)。
在这项为期 22 年的前瞻性队列研究中,出生体重与前列腺癌风险或死亡率之间没有一致的关联。